1 Miravitlles M, "What pulmonologists think about the asthma-COPD overlap syndrome" 10 : 1321-1330, 2015
2 Sin DD, "What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion" 48 : 664-673, 2016
3 Gelb AF, "Unraveling the pathophysiology of the asthma-copd overlap syndrome: unsuspected mild centrilobular emphysema is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation" 148 : 313-320, 2015
4 Bousquet J, "Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma" 126 : 926-938, 2010
5 Wurst KE, "Understanding asthma-chronic obstructive pulmonary disease overlap syndrome" 110 : 1-11, 2016
6 Reddel HK, "Treatment of overlapping asthma-chronic obstructive pulmonary disease: can guidelines contribute in an evidence-free zone?" 136 : 546-552, 2015
7 Hekking PP, "The prevalence of severe refractory asthma" 135 : 896-902, 2015
8 von Bulow A, "The prevalence of severe asthma and low asthma control among Danish adults" 2 : 759-767, 2014
9 Gibson PG, "The overlap syndrome of asthma and COPD: what are its features and how important is it?" 64 : 728-735, 2009
10 Perret JL, "The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age" 187 : 42-48, 2013
1 Miravitlles M, "What pulmonologists think about the asthma-COPD overlap syndrome" 10 : 1321-1330, 2015
2 Sin DD, "What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion" 48 : 664-673, 2016
3 Gelb AF, "Unraveling the pathophysiology of the asthma-copd overlap syndrome: unsuspected mild centrilobular emphysema is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation" 148 : 313-320, 2015
4 Bousquet J, "Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma" 126 : 926-938, 2010
5 Wurst KE, "Understanding asthma-chronic obstructive pulmonary disease overlap syndrome" 110 : 1-11, 2016
6 Reddel HK, "Treatment of overlapping asthma-chronic obstructive pulmonary disease: can guidelines contribute in an evidence-free zone?" 136 : 546-552, 2015
7 Hekking PP, "The prevalence of severe refractory asthma" 135 : 896-902, 2015
8 von Bulow A, "The prevalence of severe asthma and low asthma control among Danish adults" 2 : 759-767, 2014
9 Gibson PG, "The overlap syndrome of asthma and COPD: what are its features and how important is it?" 64 : 728-735, 2009
10 Perret JL, "The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age" 187 : 42-48, 2013
11 O'Neill S, "The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry" 70 : 376-378, 2015
12 Hardin M, "The clinical features of the overlap between COPD and asthma" 12 : 127-, 2011
13 Louie S, "The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations" 6 : 197-219, 2013
14 Bateman ED, "The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?" 3 : 719-728, 2015
15 Zeki AA, "The asthma-COPD overlap syndrome: a common clinical problem in the elderly" 2011 : 2011
16 Postma DS, "The asthma-COPD overlap syndrome" 373 : 1241-1249, 2015
17 Chen H, "Subspecialty differences in asthma characteristics and management" 83 : 786-793, 2008
18 Wenzel S, "Severe asthma: from characteristics to phenotypes to endotypes" 42 : 650-658, 2012
19 Varsano S, "Severe and non-severe asthma in the community: a large electronic database analysis" 123 : 131-139, 2017
20 Shaaban R, "Rhinitis and onset of asthma: a longitudinal population-based study" 372 : 1049-1057, 2008
21 Francesco Menzella, "Real-life Efficacy of Omalizumab After 9 Years of Follow-up" 대한천식알레르기학회 9 (9): 368-372, 2017
22 "Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society" 162 : 2341-2351, 2000
23 이진국, "Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome" 대한내과학회 30 (30): 443-449, 2015
24 Matteo Ferrando, "Personalized Medicine in Allergy" 대한천식알레르기학회 9 (9): 15-24, 2017
25 Rhee CK, "Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma" 11 : 163-170, 2014
26 Chung KF, "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma" 43 : 343-373, 2014
27 Menezes AM, "Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma" 145 : 297-304, 2014
28 Schatz M, "Improved asthma outcomes from allergy specialist care: a population-based cross-sectional analysis" 116 : 1307-1313, 2005
29 Global Initiative for Chronic Obstructive Lung Disease (GOLD), "Global strategy for the diagnosis, management and prevention of COPD [Internet]" Global Initiative for Chronic Obstructive Lung Disease
30 Global Initiative for Asthma (GINA), "Global strategy for asthma management and prevention [Internet]" Global Initiative for Asthma
31 Kim TB, "Factors associated with severity and exacerbation of asthma: a baseline analysis of the cohort for reality and evolution of adult asthma in Korea (COREA)" 103 : 311-317, 2009
32 Custovic A, "EAACI position statement on asthma exacerbations and severe asthma" 68 : 1520-1531, 2013
33 Caminati M, "Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience" 16 : 128-, 2016
34 Cazzola M, "Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome?" 138 : 977-983, 2016
35 Chung KF, "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society" 13 : 1198-1208, 1999
36 Jo YS, "Different prevalence and clinical characteristics of asthma-chronic obstructive pulmonary disease overlap syndrome according to accepted criteria" 118 : 696-703, 2017
37 Kankaanranta H, "Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines" 116 : 291-307, 2015
38 Merritt L. Fajt, "Development of New Therapies for Severe Asthma" 대한천식알레르기학회 9 (9): 3-14, 2017
39 Soler-Cataluna JJ, "Consensus document on the overlap phenotype COPD-asthma in COPD" 48 : 331-337, 2012
40 van Boven JF, "Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life" 149 : 1011-1020, 2016
41 Lamprecht B, "COPD in never smokers: results from the population-based burden of obstructive lung disease study" 139 : 752-763, 2011
42 Gibson PG, "Asthma-COPD overlap 2015: now we are six" 70 : 683-691, 2015
43 Don D. Sin, "Asthma-COPD Overlap Syndrome: What We Know and What We Don’t" 대한결핵및호흡기학회 80 (80): 11-20, 2017
44 Diaz-Guzman E, "Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population" 8 : 400-407, 2011
45 Chung KF, "Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies" 279 : 192-204, 2016
46 Lin TY, "Asthma phenotypes and endotypes" 19 : 18-23, 2013
47 Ding B, "Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights" 10 : 363-371, 2016
48 Sullivan SD, "Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients" 62 : 655-660, 2007
49 Tkacova R, "Airway hyperresponsiveness in chronic obstructive pulmonary disease: a marker of asthma-chronic obstructive pulmonary disease overlap syndrome?" 138 : 1571-1579, 2016